EcoDrugPlus

Adrenoceptor Alpha 1a

Ensembl ID : ENSHCOG00000001876
Gene Symbol: ADRA1A
3 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSHCOG00000019580
Gene Symbol: ADRA1B
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSHCOG00000017866
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSHCOG00000015819
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSHCOG00000020980
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSHCOG00000018813
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSHCOG00000005397
Gene Symbol: ADRA2C
4 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSHCOG00000021017
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSHCOG00000013015
Gene Symbol: LOC109523886
3 Cross references
343 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSHCOG00000015158
Gene Symbol: LOC109518810
3 Cross references
191 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSHCOG00000004535
Gene Symbol: LOC109526944
3 Cross references
174 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSHCOG00000013959
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).